Gencurix Inc. (229000)

Overview

Gencurix Inc. is a biomedical company focused on advancing healthcare through innovative diagnostic solutions. Founded in 2011 and based in Seoul, South Korea, Gencurix specializes in developing and providing a broad range of diagnostic tests primarily aimed at cancer detection, prognosis, and monitoring, as well as infectious disease detection. Leveraging cutting-edge biotechnology, Gencurix is committed to contributing to the global healthcare industry by enhancing the accuracy and efficiency of disease diagnosis, which is crucial for effective treatment and patient care.

Products and Services

• GenesWell BCT: A prognosis diagnostic test specifically for breast cancer. This test helps in predicting the likelihood of breast cancer recurrence in patients, facilitating personalized treatment planning.
• GenesWell ddEGFR Mutation Test: A companion diagnostic test used in the context of lung cancer. It is designed to detect the presence of specific mutations in the EGFR gene, aiding in selecting appropriate targeted therapies for lung cancer patients.
• Droplex: A genetic test capable of detecting a wide range of DNA mutations. This versatile diagnostic tool is applicable in various contexts, including cancer diagnostics and genetic disorder identification.
• eDX: An early diagnosis tool for cancer that employs liquid biopsy technology. By analyzing circulating tumor DNA from blood samples, eDX aims to offer a non-invasive alternative for cancer detection and monitoring.
• GenePro COVID-19 detection test: A diagnostic test developed for the specific detection of the SARS-CoV-2 virus. This test plays a critical role in identifying COVID-19 cases, contributing to the global effort to control the pandemic.
• GenePro SARS-CoV-2 Test kit: Another tool in the fight against COVID-19, this kit is designed for the efficient and accurate detection of the virus responsible for the disease, helping in the quick identification and isolation of affected individuals.
• GenoCTC (circulating tumor cell isolator): A specialized device designed for isolating circulating tumor cells (CTCs) from blood samples. CTCs are a key indicator of cancer presence and metastatic activity, making this tool valuable for cancer prognosis and monitoring.
• GenePro LAMP test solution: A rapid, convenient, and simple testing solution for various infectious diseases using loop-mediated isothermal amplification (LAMP) technology. This approach allows for fast and accurate disease detection, crucial for effective treatment and containment.
• GenePro LAMP Cycler: A device that facilitates the LAMP test process. It is designed to perform loop-mediated isothermal amplification, enabling the detection of infectious diseases with high efficiency and reliability.